A Curated Platform of Equity & Options Market Intelligence
Select Page

Joe Kunkle

Tags

Asset Class

Style

Level

Search by Ticker Symbol

Unusual Call Buy in Solid Looking Oncology Play

Culligan Oncology (CGEM) unusual buy of 500 October $20 calls for $3.20, nice long consolidation flag forming and $750M low short float Biotech trading less than 2X Cash. CLN-619 data expected in Q2. Wedbush in February with a $30 target saying Cullinan Oncology has a...

read more

Unusual Call Buy in Neuro Biotech

Neumora Therapeutics (NMRA) jumps here with an unusual buy of 1500 December $17.50 calls for $4.70. The $2.2B Biotech trades 5X Cash with 10% of the float short and estimates for $425M sales in FY28. RBC out defending shares on 3/13 after the lock-up expiration...

read more